Author: Celia Chen
Chen, Celia, 2011 Optimizing the management of Central Retinal Artery Occlusion, Flinders University, School of Medicine
This electronic version is made publicly available by Flinders University in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exceptions. If you are the owner of any included third party copyright material and/or you believe that any material has been made available without permission of the copyright owner please contact email@example.com with the details.
The aim underpinning this thesis is to define the best management of acute central retinal artery occlusion (CRAO). Currently, there are no effective treatments for this condition and patients often suffer profound, permanent vision loss. In this thesis, I review the literature on the current management of acute CRAO and evaluate subsequent visual outcomes. The management of CRAO involves three aspects: early reperfusion, treatment of secondary vascular risk factors and potential treatment of local ocular complications. Early reperfusion strategies can be broadly divided as non-thrombolytic and thrombolytic. Non-thormbolytic treatments include measures such as ocular massage to dislodge the embolus and paracentesis to change the perfusion pressure across the optic nerve head. The management of acute management of CRAO is at the discretion of individual ophthalmologist and can vary significantly. I review the current practice in two teaching hospitals and show that despite differences in management of CRAO between two institutions in different countries, visual outcomes are similar. This suggests a lack of efficacy of current standard treatment in acute CRAO. Thrombolytics have emerged as potential therapeutic options and I evaluated the feasibility of the novel treatment option of thrombolytic in the treatment of acute CRAO. This showed that thrombolysis is a biologically feasible treatment option in acute CRAO and patients receiving thrombolysis had a better visual outcome than those treated with standard therapy alone. A clinical trial protocol designed to evaluate the effect of acute intravenous tissue plasminogen activator in CRAO was developed and I report on the outcomes of this randomized controlled trial. In the management of secondary vascular risk factors, a high proportion of patients presenting with CRAO often have an undiagnosed vascular risk factor. In this study, 64% of patients had at least one undiagnosed vascular risk factor and a significant proportion required either the addition or escalation of existing macrovascular preventative medications and 18% required surgical intervention for carotid recanalization. As this population is at high risk of secondary ischaemic events, risk factor modification is prudent to prevent further ischemic events. Neovascularisation is a local ocular complication following CRAO and in our study, the overall rate of neovascularisation was 18.2%. There was a clear empirical correlation between thromboembolic CRAO and neovascularisation. Given the association between neovascularisation and CRAO, prudent clinical practice would be to review all patients with acute CRAO at regular intervals as early as 2 weeks and up to 4 months post CRAO. The results from this thesis showed that for now, the use of intravenous thrombolysis cannot be recommended in routine clinical practice in acute CRAO. Further studies are required to determine the optimal time window for treatment and the adjuvant therapies for thrombolysis. I discuss the optimal management to limit the ocular neovascular complications and investigations to optimize the systemic atherosclerotic risk factors to reduce secondary ischemic events after CRAO.
Keywords: Central retinal artery occlusion,thrombolysis,systemic,ischemia,acute management
Subject: Ophthalmology thesis
Thesis type: Doctor of Philosophy
School: School of Medicine
Supervisor: Professors Doug Coster and Keryn Williams